女性肺癌的治疗方法
Marisa Sewell1, Daniela Molena1
1Department of Surgery, Thoracic Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Surgical oncology clinics of North America
|October 19, 2025
概括
全球肺癌发病率在男性下降,但在女性上升. 患有肺癌的女性表现出明显的临床差异,但在临床试验中代表性不足.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 临床研究 临床研究
背景情况:
- 肺癌是美国癌症死亡的主要原因之一.
- 全球肺癌发病率和死亡率在男性下降,但在女性上升.
- 男性和女性肺癌患者之间存在显著的临床,病理和生存差异.
研究的目的:
- 突出男性和女性肺癌的流行病学趋势.
- 为了强调肺癌中性别之间的临床和病理差异.
- 解决女性在未来肺癌临床试验中的代表性不足问题.
主要方法:
- 全球肺癌发病率和死亡率数据的综述.
- 对临床,病理和生存数据的分析,按性别分层.
- 评估女性参与手术和非手术肺癌临床试验的情况.
主要成果:
- 全球肺癌死亡率在男性中正在下降,但在女性中正在增加.
- 在患有肺癌的女性中观察到明显的临床和病理特征.
- 在未来的肺癌临床试验中,女性的代表性明显不足.
结论:
- 肺癌的流行病学趋势和临床表现在性别之间存在差异.
- 在临床试验中女性的代表性不足可能会阻碍性别特异性治疗的发展.
- 需要进一步的研究和试验包容性,以解决肺癌护理中的基于性别的差异.
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K


